Biomimetic Bacterial Membrane Models for Comprehending Membrane Dynamics.

J Membr Biol

Biosciences and Bioengineering Division, CSIR-National Institute for Interdisciplinary Science and Technology (NIIST), Trivandrum, Kerala, 695019, India.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00232-025-00351-6DOI Listing

Publication Analysis

Top Keywords

biomimetic bacterial
4
bacterial membrane
4
membrane models
4
models comprehending
4
comprehending membrane
4
membrane dynamics
4
membrane
2
biomimetic
1
models
1
comprehending
1

Similar Publications

Outer membrane vesicle-coated ferrocene nanoparticles induce dual ferroptosis for cancer immunotherapy.

J Control Release

September 2025

School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China. Electronic address:

Fusobacterium nucleatum (Fn.) can colonize breast cancer tissue to promote tumor progression by inducing immunosuppression. Targeted therapeutic strategies against intratumoral bacteria remain unexplored and have potential in tumor immunotherapy.

View Article and Find Full Text PDF

Biomimetic membrane nanotechnology in cerebral ischemic stroke:a promising technology for therapeutic treatment and diagnosis.

Front Bioeng Biotechnol

August 2025

NHC Key Laboratory of Nuclear Technology Medical Transformation, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.

Cerebral ischemic stroke (CIS) is a severe cerebrovascular disease that poses numerous challenges in diagnosis and treatment, primarily attributed to blood-brain barrier (BBB) constraints and inherent drug targeting limitations. Biomimetic membrane nanotechnology, as an emerging therapeutic approach, offers a novel therapeutic strategy by emulating biological membrane structures and functions. This review comprehensively examines biomimetic nanomedicines (BMNPs) in CIS management, encompassing preparation methodologies, material characterization, and specific diagnostic/therapeutic applications.

View Article and Find Full Text PDF

SEE-phAST: Spatially encapsulated emulsions for phenotypic antibiotic susceptibility testing via sequential digital RAA-CRISPR.

Biosens Bioelectron

August 2025

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine Vision and Brain Health), Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, China; Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, 1

The escalating threat of antimicrobial resistance is exacerbated by delayed diagnostics and improper antibiotics use, underscoring an urgent demand for rapid, versatile AST tools to support evidence-based prescribing. In this study, we present an innovative, generalizable phenotypic AST approach by quantifying bacterial gDNA copy number variations (CNVs) following 0.5-h-brief culturing with antibiotic exposure, termed spatially encapsulated emulsions (SEE)-phAST.

View Article and Find Full Text PDF

Bacterial biofilms contribute to 60%-80% of human infections, exhibiting resistance to traditional antibiotic treatment and contributing to chronic, relapsing diseases, particularly in healthcare settings. Traditional in-vitro and in-vivo models often fail to accurately replicate the human microenvironment. This mini review highlights the emerging use of organoid-based models that are three-dimensional, self-organizing structures derived from stem cells.

View Article and Find Full Text PDF

Biomimetic mineralization material RMCP enhanced immunogenicity of subunit vaccine against Clostridium perfringens infection in mice.

Int J Biol Macromol

September 2025

Heilongjiang Provincial Key Laboratory of Zoonosis, College of Veterinary Medicine, Northeast Agricultural University, Harbin, China. Electronic address:

Subunit vaccines offer high biosafety but face limited immunogenicity. In this study, we utilized a biomimetic mineralization strategy, rhamnolipid-modified manganese-doped calcium phosphate nanoparticles (RMCP), to enhance the immunogenicity of subunit vaccines based on-bacterial-like particle (BLPs). Subcutaneous administration of the developed vaccine, which is prepared by encapsulating BLP vaccine with RMCP (named RMCP@COB17) enhanced significantly elevated serum IgG antibody levels in mice, induced a Th1/Th2-balanced immune response, and promoted the secretion of cytokines such as IFN-γ and IL-12.

View Article and Find Full Text PDF